ScholarIQanswers from OpenAlex

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

PaperCitations, authors & open-access status

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease have?

ScholarIQcitation count

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease has 9,298 citations in the OpenAlex counts ScholarIQ stores.

When was Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease published?

ScholarIQyear

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease has 2017 year in the ScholarIQ index.

What is the open-access status of Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease?

ScholarIQoa status

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease has bronze oa status in the ScholarIQ index.

What is the DOI of Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease?

ScholarIQdoi

The DOI for Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease is on the source record.

What is the PMID of Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease?

ScholarIQpmid

The PMID for Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease is on the source record.

What is the OpenAlex record for Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease?

ScholarIQopenalex

The OpenAlex for Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial